製品名:6,7-dimethoxyquinolin-4-ol

IUPAC Name:6,7-dimethoxyquinolin-4-ol

CAS番号:13425-93-9
分子式:C11H11NO3
純度:97%
カタログ番号:CM104728
分子量:205.21

包装単位 有効在庫 価格(USD) 数量
CM104728-100g in stock ƎƦȬ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:13425-93-9
分子式:C11H11NO3
融点:-
SMILESコード:COC1=C(OC)C=C2C(O)=CC=NC2=C1
密度:
カタログ番号:CM104728
分子量:205.21
沸点:
MDL番号:MFCD07368026
保管方法:

Category Infos

Quinolines
Quinolines are an important class of biologically active heterocyclic compounds, and their derivatives usually exhibit a variety of biological activities. They can be used as antimalarial drugs and in the preparation of other antimalarial drugs. Other important activities of quinoline derivatives include inhibitory activity against EGFR-TK and antipsychotic activity. Futhermore, quinoline scaffolds are present in various drug molecules, including the antimalarial drugs aablaquine, chloroquine, mefloquine and primaquine, and the antibacterial agents gatifloxacin, levofloxacin, and moxifloxacin.
Quinoline Price
if you have any question on quinoline price, we will give the professional answers to your short questions.

Column Infos

Cabozantinib
On August 21, 2023, Exelixis and Ipsen announced that the global phase 3 CONTACT-02 study of cabozantinib (Cabometyx ®) in combination with atezolizumab for metastatic castration-resistant prostate cancer (mCRPC) met the primary endpoint of progression-free survival (PFS) in an interim analysis.
Prostate cancer is the fourth most common cancer worldwide and the second most common cancer among men. At present, the drugs approved for the treatment of CRPC are basically AR inhibitors or PARP inhibitors, and the combination therapy of Cabozantinib + Atezolizumab is expected to become a new treatment option for such patients.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products